Evidence map›Paper›PMID 24667581›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2014

Chemoprevention of esophageal cancer with black raspberries, their component anthocyanins, and a major anthocyanin metabolite, protocatechuic acid.

Daniel S Peiffer, Noah P Zimmerman, Li-Shu Wang, Benjamin W S Ransom, Steven G Carmella, Chieh-Ti Kuo, Jibran Siddiqui, Jo-Hsin Chen, Kiyoko Oshima, Yi-Wen Huang and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 2 syntheses or guidelines pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Berries vs. Disease: Revenge of the Phytochemicals.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Daniel S PeifferAuthors' Affiliations: Departments of Medicine, Pathology, and Obstetrics and Gynecology, Medical College of Wisconsin Cancer Center; Agro BioSciences Inc., Milwaukee, Wisconsin; and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Noah P ZimmermanAuthors' Affiliations: Departments of Medicine, Pathology, and Obstetrics and Gynecology, Medical College of Wisconsin Cancer Center; Agro BioSciences Inc., Milwaukee, Wisconsin; and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Li-Shu WangAuthors' Affiliations: Departments of Medicine, Pathology, and Obstetrics and Gynecology, Medical College of Wisconsin Cancer Center; Agro BioSciences Inc., Milwaukee, Wisconsin; and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Benjamin W S RansomAuthors' Affiliations: Departments of Medicine, Pathology, and Obstetrics and Gynecology, Medical College of Wisconsin Cancer Center; Agro BioSciences Inc., Milwaukee, Wisconsin; and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Steven G CarmellaAuthors' Affiliations: Departments of Medicine, Pathology, and Obstetrics and Gynecology, Medical College of Wisconsin Cancer Center; Agro BioSciences Inc., Milwaukee, Wisconsin; and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Chieh-Ti KuoAuthors' Affiliations: Departments of Medicine, Pathology, and Obstetrics and Gynecology, Medical College of Wisconsin Cancer Center; Agro BioSciences Inc., Milwaukee, Wisconsin; and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Jibran SiddiquiAuthors' Affiliations: Departments of Medicine, Pathology, and Obstetrics and Gynecology, Medical College of Wisconsin Cancer Center; Agro BioSciences Inc., Milwaukee, Wisconsin; and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Jo-Hsin ChenAuthors' Affiliations: Departments of Medicine, Pathology, and Obstetrics and Gynecology, Medical College of Wisconsin Cancer Center; Agro BioSciences Inc., Milwaukee, Wisconsin; and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Kiyoko OshimaAuthors' Affiliations: Departments of Medicine, Pathology, and Obstetrics and Gynecology, Medical College of Wisconsin Cancer Center; Agro BioSciences Inc., Milwaukee, Wisconsin; and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Yi-Wen HuangAuthors' Affiliations: Departments of Medicine, Pathology, and Obstetrics and Gynecology, Medical College of Wisconsin Cancer Center; Agro BioSciences Inc., Milwaukee, Wisconsin; and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Stephen S HechtAuthors' Affiliations: Departments of Medicine, Pathology, and Obstetrics and Gynecology, Medical College of Wisconsin Cancer Center; Agro BioSciences Inc., Milwaukee, Wisconsin; and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Gary D StonerAuthors' Affiliations: Departments of Medicine, Pathology, and Obstetrics and Gynecology, Medical College of Wisconsin Cancer Center; Agro BioSciences Inc., Milwaukee, Wisconsin; and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota gstoner@mcw.edu.
University of Minnesota · USUniversity of Minnesota Medical Center · US

Funding

Prevention of Esophageal Cancer with BerriesR01CA103180 · NCI · OHIO STATE UNIVERSITY · PI STONER, GARY · 2003 to 2013
$4.0M
Mechanisms of tumor suppressor gene reactivation in colon cancer by berriesR01CA148818 · NCI · OHIO STATE UNIVERSITY · PI WANG, LI-SHU · 2010 to 2014
$1.5M
NCI NIH HHS 5 R01 CA103180 09NCI NIH HHS 5 R01 CA148818 04NCI NIH HHS R01 CA103180NCI NIH HHS R01 CA148818
6 · The paper itself

Abstract

Diets containing either freeze-dried black raspberries (BRBs) or their polyphenolic anthocyanins (ACs) have been shown to inhibit the development of N-nitrosomethylbenzylamine (NMBA)-induced esophageal cancer in rats. The present study was conducted to determine whether PCA, a major microbial metabolite of black raspberry (BRB) ACs, also prevents NMBA-induced esophageal cancer in rats. F344 rats were injected with NMBA three times a week for 5 weeks and then fed control or experimental diets containing 6.1% BRBs, an anthocyanin (AC)-enriched fraction derived from BRBs, or protocatechuic acid (PCA). Animals were exsanguinated at weeks 15, 25, and 35 to quantify the development of preneoplastic lesions and tumors in the esophagus, and to relate this to the expression of inflammatory biomarkers. At weeks 15 and 25, all experimental diets were equally effective in reducing NMBA-induced esophageal tumorigenesis, as well as in reducing the expression of pentraxin-3 (PTX3), a cytokine produced by peripheral blood mononuclear cells in response to interleukin (IL)-1β and TNF-α. All experimental diets were also active at reducing tumorigenesis at week 35; however, the BRB diet was significantly more effective than the AC and PCA diets. Furthermore, all experimental diets inhibited inflammation in the esophagus via reducing biomarker (COX-2, iNOS, p-NF-κB, and sEH) and cytokine (PTX3) expression. Overall, our data suggest that BRBs, their component ACs, and PCA inhibit NMBA-induced esophageal tumorigenesis, at least in part, by their inhibitory effects on genes associated with inflammation.

Indexed as

Diet TherapyRubusAnimalsAnthocyaninsAnticarcinogenic AgentsChemopreventionDimethylnitrosamineEsophageal NeoplasmsFruitHydroxybenzoatesMalePlant ExtractsPrecancerous ConditionsRatsRats, Inbred F344AnthocyaninsAnticarcinogenic AgentsDimethylnitrosamineHydroxybenzoatesnitrosobenzylmethylaminePlant Extractsprotocatechuic acid

Identifiers

PMID24667581
PMCPMC6108893
OpenAlexW2129623765

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.